Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion to Rytary in Advanced Parkinson's Disease
NCT01411137Phase 3Completed
- Sponsor
- Impax Laboratories
- Start
- Aug 2011
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of carbidopa + levodopa in Parkinson's disease (PD), sponsored by Impax Laboratories. Started Aug 2011; status: completed.
02
Drugs
carbidopa + levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01411137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01411137.